Document is current
Any future updates will be listed below
-
Authors
Karimzadeh, Mehran https://orcid.org/0000-0002-7324-6074
Momen-Roknabadi, Amir
Cavazos, Taylor B.
Fang, Yuqi
Chen, Nae-Chyun
Multhaup, Michael
Yen, Jennifer
Ku, Jeremy
Wang, Jieyang
Zhao, Xuan
Murzynowski, Philip
Wang, Kathleen
Hanna, Rose
Huang, Alice
Corti, Diana
Nguyen, Dang
Lam, Ti
Kilinc, Seda
Arensdorf, Patrick
Chau, Kimberly H.
Hartwig, Anna
Fish, Lisa
Li, Helen https://orcid.org/0000-0002-1145-6527
Behsaz, Babak
Elemento, Olivier https://orcid.org/0000-0002-8061-9617
Zou, James https://orcid.org/0000-0001-8880-4764
Hormozdiari, Fereydoun https://orcid.org/0000-0003-2703-9274
Alipanahi, Babak https://orcid.org/0000-0001-8216-7178
Goodarzi, Hani https://orcid.org/0000-0002-9648-8949
- License Information
-
More Information
Article History
Received: 21 May 2024
Accepted: 22 October 2024
First Online: 21 November 2024
Competing interests
: The authors are either employees, shareholders, or stock option holders of Exai Bio, Inc. B.A., H.G., F.H., and M.K. have a pending patent application (U.S. Patent “Systems and Methods for Early-Stage Cancer Detection and Subtyping” Application Serial No. 18/636,128 and International Application No. PCT/US24/24682) related to this work.
